THC and Alzheimer’s Agitation
THC for Alzheimer’s agitation is drawing attention after a randomized placebo-controlled dronabinol trial reported short-term reductions in agitation scores. The study is clinically meaningful because dementia-related agitation can be devastating for…
HLB Life Science R&D Leads Korea CBD Drug Ingredient Push in National Project
Pharmaceutical-grade CBD development Korea is advancing rapidly with HLB Life Science leading a national project. This initiative marks a shift in Asia's regulatory approach to cannabinoid medicine. It aims to establish pharmaceutical-grade CBD…
Cannabis Regulation in Sports – The Cureus Journal of Medical Science
This article covers cannabis regulation sports developments with clinical relevance. It highlights important evidence and policy updates from the Cureus Journal of Medical Science. Clinicians and sports professionals should review this focus area…
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav … – Investors
Jazz Pharmaceuticals continues pharmaceutical CBD research with new presentations on Epidiolex. These studies focus on expanding evidence-based cannabinoid medicine beyond approved epilepsy indications. Pharmaceutical CBD research informs off-label…
Hawaii Senators Advance Cannabis Legalization Bills Amid 2026 Reform Efforts
Hawaii cannabis legalization bills are gaining traction in 2026 as senators advance key proposals. The state’s efforts reflect growing momentum despite federal uncertainty. These bills mark significant progress in Hawaii's cannabis reform landscape.
Cannabinoids as promising anti-tumor drugs in prostate cancer
Cannabinoids prostate cancer research shows promising anti-tumor effects by targeting cannabinoid receptors. These compounds regulate cancer progression and fibroblast activation. Cannabinoids prostate cancer therapy may impair tumor growth and…